A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2685584
The present invention concerns a molecule binding to LAG-3 protein and causing depletion of LAG-3' activated T cells particularly said molecule is a cytotoxic anti-LAG-3 monoclonal antibody or fragment thereof. It also concerns a method of treating or preventing organ transplant rejection or autoimmune diseases in a mammal comprising administering to said mammal a therapeutically effective amount of said antibody.
La présente invention porte sur une molécule se liant à la protéine LAG-3 et provoquant un épuisement de lymphocytes T activés par LAG-3'. En particulier, ladite molécule est un anticorps monoclonal anti-LAG-3 cytotoxique ou un fragment de celui-ci. L'invention porte également sur un procédé de traitement ou de prévention d'un rejet de greffon d'organe ou de maladies auto-immunes dans un mammifère, comprenant l'administration audit mammifère d'une quantité thérapeutiquement efficace dudit anticorps.
Haudebourg Thomas
Triebel Frederic
Vanhove Bernard
Immutep
Inserm-Institut National de La Sante Et de La Recherche Medicale
Smart & Biggar
LandOfFree
Cytotoxic anti-lag-3 monoclonal antibody and its use in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic anti-lag-3 monoclonal antibody and its use in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic anti-lag-3 monoclonal antibody and its use in the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1444147